ELI LILLY AND COMPAN

LLY
Delayed Quote. Delayed  - 11/25 03:55:31 pm
144.59USD -0.21%
Prev.144.9000
Open144.9000
High145.3400
Low142.6100
Volume2 036 066
Latest news
6h ago
1d ago
1d ago
1d ago
Chart ELI LILLY AND COMPANY
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance149169166
Spread/Res.-2,6%-14%-13%
Spread/Supp.3,6%11%18%
Support140130122
Financials
Sales 2020 23 681 M - -
Net income 2020 6 011 M - -
Net Debt 2020 11 184 M - -
P/E ratio 2020 22,7x
Yield 2020 2,04%
Capitalization 131 B 131 B -
EV / Sales 2020 6,02x
EV / Sales 2021 5,39x
Nbr of Employees 33 625
Free-Float 99,8%
Company
Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or...

>> Read more
Sector :
Pharmaceuticals - NEC
Calendar :
2020-12-15 Guidance Call
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 164,58 $
Last Close Price 144,90 $
Spread / Highest target 38,0%
Spread / Average Target 13,6%
Spread / Lowest Target -17,2%